Qi J - Search Results

1

Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia.

Zhao N, Pei SN, Qi J, Zeng Z, Iyer SP, Lin P, Tung CH, Zu Y. Zhao N, et al. Among authors: qi j. Biomaterials. 2015 Oct;67:42-51. doi: 10.1016/j.biomaterials.2015.07.025. Epub 2015 Jul 15. Biomaterials. 2015. PMID: 26204224 Free PMC article.

2

Targeted immunotherapy of triple-negative breast cancer by aptamer-engineered NK cells.

Chen Z, Zeng Z, Wan Q, Liu X, Qi J, Zu Y. Chen Z, et al. Among authors: qi j. Biomaterials. 2022 Jan;280:121259. doi: 10.1016/j.biomaterials.2021.121259. Epub 2021 Nov 15. Biomaterials. 2022. PMID: 34801254 Free PMC article.

3

Aptamer-Gemcitabine Conjugates with Enzymatically Cleavable Linker for Targeted Delivery and Intracellular Drug Release in Cancer Cells.

Qi J, Zeng Z, Chen Z, Nipper C, Liu X, Wan Q, Chen J, Tung CH, Zu Y. Qi J, et al. Pharmaceuticals (Basel). 2022 Apr 30;15(5):558. doi: 10.3390/ph15050558. Pharmaceuticals (Basel). 2022. PMID: 35631384 Free PMC article.

4

Transfecting the hard-to-transfect lymphoma/leukemia cells using a simple cationic polymer nanocomplex.

Zhao N, Qi J, Zeng Z, Parekh P, Chang CC, Tung CH, Zu Y. Zhao N, et al. Among authors: qi j. J Control Release. 2012 Apr 10;159(1):104-10. doi: 10.1016/j.jconrel.2012.01.007. Epub 2012 Jan 15. J Control Release. 2012. PMID: 22269663 Free PMC article.

5

Total control of fat cells from adipogenesis to apoptosis using a xanthene analog.

Tung CH, Han MS, Qi J. Tung CH, et al. Among authors: qi j. PLoS One. 2017 Jun 5;12(6):e0179158. doi: 10.1371/journal.pone.0179158. eCollection 2017. PLoS One. 2017. PMID: 28582464 Free PMC article.

6

Aptamer-Engineered Natural Killer Cells for Cell-Specific Adaptive Immunotherapy.

Yang S, Wen J, Li H, Xu L, Liu Y, Zhao N, Zeng Z, Qi J, Jiang W, Han W, Zu Y. Yang S, et al. Among authors: qi j. Small. 2019 May;15(22):e1900903. doi: 10.1002/smll.201900903. Epub 2019 Apr 26. Small. 2019. PMID: 31026116 Free PMC article.

7

Rapid Detection of Mycoplasma-Infected Cells by an ssDNA Aptamer Probe.

Liu Y, Jiang W, Yang S, Hu J, Lu H, Han W, Wen J, Zeng Z, Qi J, Xu L, Zhou H, Sun H, Zu Y. Liu Y, et al. Among authors: qi j. ACS Sens. 2019 Aug 23;4(8):2028-2038. doi: 10.1021/acssensors.9b00582. Epub 2019 Aug 12. ACS Sens. 2019. PMID: 31403764

8

Aptamers with Self-Loading Drug Payload and pH-Controlled Drug Release for Targeted Chemotherapy.

Zeng Z, Qi J, Wan Q, Zu Y. Zeng Z, et al. Among authors: qi j. Pharmaceutics. 2021 Aug 7;13(8):1221. doi: 10.3390/pharmaceutics13081221. Pharmaceutics. 2021. PMID: 34452182 Free PMC article.

9

Aptamer-armed nanostructures improve the chemotherapy outcome of triple-negative breast cancer.

Wan Q, Zeng Z, Qi J, Chen Z, Liu X, Zu Y. Wan Q, et al. Among authors: qi j. Mol Ther. 2022 Jun 1;30(6):2242-2256. doi: 10.1016/j.ymthe.2022.02.004. Epub 2022 Feb 8. Mol Ther. 2022. PMID: 35143958 Free PMC article.

10

Aptamer Targets Triple-Negative Breast Cancer through Specific Binding to Surface CD49c.

Wan Q, Zeng Z, Qi J, Zhao Y, Liu X, Chen Z, Zhou H, Zu Y. Wan Q, et al. Among authors: qi j. Cancers (Basel). 2022 Mar 18;14(6):1570. doi: 10.3390/cancers14061570. Cancers (Basel). 2022. PMID: 35326720 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,637 results

Search Page

Filters